This inventor holds 1 USPTO granted patent. Top assignee: Minoryx Therapeutics S.l.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Ana María García Collazo: Innovator in CNS Treatment
Introduction
Ana María García Collazo is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of medicine, particularly in the treatment of central nervous system disorders. His innovative work has led to the development of novel compounds that hold promise for therapeutic applications.
Latest Patents
Ana María García Collazo holds a patent for 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders. The patent describes the compound 5-(4-(2-(5-(1-hydroxyethyl)pyridine-2-yl)ethoxy) benzyl)thiazolidine-2,4-dione and its novel stereoisomers. This invention aims to provide effective treatment options for various CNS disorders.
Career Highlights
Ana María is associated with Minoryx Therapeutics S.L., a company focused on developing innovative therapies for rare diseases. His work at Minoryx Therapeutics has been instrumental in advancing research and development in the pharmaceutical industry.
Collaborations
Ana María has collaborated with notable colleagues, including David John Augustus Eckland and Maria Pilar Pizcueta Lalanza. These partnerships have enhanced the research efforts and broadened the scope of their innovative projects.
Conclusion
Ana María García Collazo is a key figure in the field of CNS treatment, with a patent that showcases his innovative approach to addressing complex medical challenges. His contributions continue to impact the pharmaceutical landscape positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile